Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × Buspirone × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 19 Fluorouracil 17 Gemcitabine 14 Radiotherapy 13 Paclitaxel 13 Docetaxel 13 Oxaliplatin 12 Cyclophosphamide 11 Carboplatin 11 Capecitabine 11 Bevacizumab 11 Drug Therapy 10 Leucovorin 9 Cytarabine 9 Irinotecan 8 Magnetic Resonance Spectroscopy 7 Dexamethasone 7 Saline Solution 6 Methotrexate 6 Letrozole 6 Exercise 6 Etoposide 6 pembrolizumab 5 Rituximab 5 Nivolumab 5 Melphalan 5 Lidocaine 5 Filgrastim 5 Electroporation 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00053846 2015-11-24

Buspirone in Reducing Shortness of Breath in Patients With Cancer

University of Rochester

Phase 2/3 Completed

432 enrolled 16 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡